Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston
3
×
boston blog main
boston top stories
deals
3
×
life sciences
national blog main
clinical trials
san francisco blog main
startups
480 biomedical
abbvie
allergan
alzheimer's disease
arsenal medical
azacitidine
beta-thalassemia
bob langer
chronic rhinosinusitis
covid-19
crispr
cynthia collins
dacogen
decitabine
dna
drug delivery
editas medicine
epigenetics
epizyme
farydak
fda
flagship pioneering
fulcrum therapeutics
gene editing
genzyme
george whitesides
inflammation
insulated genomic domains
investing
ipo
What
biotech
3
×
developing
medicines
new
research
therapeutics
abbvie
aims
alliance
approach
based
called
company
debut
debuts
drugs
editas
editing
epigenetic
epigenetics
exits
experimental
field
flagship’s
gene
genetic
ipo
late
lyra
markets
million
morning
nose
noses
omega
pact
partnership
persistently
pruning
public
Language
unset
Current search:
biotech
×
boston
×
deals
×
@xconomy.com
3 years ago
AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further